A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

about

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

Item

http://www.wikidata.org/entity/Q55361498

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@en

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@nl

type

Item

label

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@en

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@nl

prefLabel

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@en

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@nl

P1476

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

@en

P2093

Antonello Giordano

http://www.w3.org/2001/XMLSchema#string

Antonio Pisani

http://www.w3.org/2001/XMLSchema#string

Carmela Zizzo

http://www.w3.org/2001/XMLSchema#string

Eleonora Riccio

http://www.w3.org/2001/XMLSchema#string

Giovanni Duro

http://www.w3.org/2001/XMLSchema#string

Giuseppe Cammarata

http://www.w3.org/2001/XMLSchema#string

Michaela Montalbano

http://www.w3.org/2001/XMLSchema#string

Paolo Colomba

http://www.w3.org/2001/XMLSchema#string

Riccardo Alessandro

http://www.w3.org/2001/XMLSchema#string

Simone Scalia

http://www.w3.org/2001/XMLSchema#string

P2860

miR-126 regulates angiogenic signaling and vascular integrity

Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death

MicroRNA dysregulation in diabetic ischemic heart failure patients

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

Mammalian microRNAs predominantly act to decrease target mRNA levels

Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects

Regulation of microRNA biogenesis

Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry

Enhanced endothelium-dependent vasodilation in Fabry disease

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

P304

27333-27345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25542

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29937989

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

P932

6007950

http://www.w3.org/2001/XMLSchema#string